Akero Therapeutics Inc (AKRO)
31.20
+0.56
(+1.84%)
USD |
NASDAQ |
Nov 21, 16:00
31.22
+0.02
(+0.06%)
After-Hours: 20:00
Akero Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Madrigal Pharmaceuticals Inc | 82.20% |
| 89bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 6.766 |
| Beta (5Y) | -0.2547 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.1% |
| Historical Sharpe Ratio (5Y) | 0.0344 |
| Historical Sortino (5Y) | 0.0713 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.01% |